Theravance Biopharma (TBPH) P/E (2014 - 2026)
Theravance Biopharma (TBPH) P/E from Jun 30, 2014 to Jul 21, 2026. The TTM Theravance Biopharma (TBPH) P/E is 12.19. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Theravance Biopharma (TBPH)
| Year | P/E | Change |
|---|---|---|
| 2026 | 12.19 | -21.46% |
| 2025 | 15.53 | -153.40% |
| 2024 | -29.08 | +156.40% |
| 2023 | -11.34 | -1386.54% |
| 2022 | 0.88 | -122.69% |
| 2021 | -3.88 | -4.51% |
| 2020 | -4.07 | -34.37% |
| 2019 | -6.20 | -5.47% |
| 2018 | -6.56 | +16.81% |
| 2017 | -5.61 | -31.50% |
| 2016 | -8.20 | +161.68% |
| 2015 | -3.13 | +15.26% |
| 2014 | -2.72 | N/A |
Comparison Theravance Biopharma (TBPH) P/E with competitors
Theravance Biopharma (TBPH) P/E is 12.19.